Latest News
The winter 2019 edition of the National Glaucoma Research Report provides answers to the top five questions asked about glaucoma, describes a new method to inhibit inflammation and prevent glaucoma, lists several apps for people with low vision, outlines a clinical research study underway to save sight from glaucoma, and more.
New approaches to lowering eye pressure, a technique that may increase understanding of how glaucoma occurs, helpful information on how eye pressure is measured, lifestyle tips to promote eye health, and more are found in the fall 2018 edition of National Glaucoma Research Report.
Learn how medications, diseases, and trauma can cause an eye condition called secondary glaucoma, explore how laser procedures are used in the treatment of glaucoma, understand how volunteers are supporting an important clinical trial to save sight, and much more in the spring 2018 edition of National Glaucoma Research Report.
Two new pressure-lowering glaucoma medications have been approved by the FDA and are becoming available in the United States. Each is unique, and one is the first in a new class of drugs.
The winter 2018 edition of the National Glaucoma Research Report has information on a BrightFocus research grant that is leading to a new understanding of glaucoma, an article outlining the connection between diabetes and glaucoma, helpful facts about how clinical trials work, and much more.
A promising new strategy to protect the optic nerve in glaucoma, helpful information on clinical trials and why they are so important, and a study exploring the genes involved in closed-angle glaucoma, are among the articles available in the fall edition of the National Glaucoma Research Report.
The summer edition of National Glaucoma Research Report outlines new research into the causes of glaucoma, drug screenings, and therapeutic strategies by generating retinal ganglion cells in a dish; a Q/A with Jeffrey Goldberg, MD, PhD on the frontlines of discovery; a spotlight on Meredith Gregory-Ksander, PhD, and her research that may stop glaucoma development and vision loss; and much more.